U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07120100) titled 'Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors' on July 30.
Brief Summary: The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Breast Cancer Female
Gynecologic Cancer
Intervention:
DEVICE: rTMS
Repetitive Transcranial Magnetic Stimulation will be administered Monday-Friday for two weeks (10 sessions total)
Recruitment Status: NOT...